Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2023

Feb 14, 2023

30786_dirs_2023-02-14_41d475b9-fd04-40dd-8d07-183e69e27cc1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2023-02-10

Reporting Person: RAMALINGAM AJIT (SVP, Chief Accounting Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-02-10 Restricted Stock Units $0 A 644 Acquired Bio-Rad A Common Stock (644) Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F2: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.